Genelux Corporation Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.79 | $157.41 M | -2.5 | 51 | $0 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$4.00 | $120.37 M | -1.65 | 384 | $380.79 M |
CELC
Celcuity Inc. |
$12.53 | $501.59 M | -5.14 | 55 | $0 |
CGEM
Cullinan Oncology, Inc. |
$12.27 | $1.29 B | -7.16 | 85 | $0 |
CING
Cingulate Inc. |
$4.86 | $4.50 M | -0.04 | 13 | $0 |
CMPX
Compass Therapeutics, Inc. |
$1.50 | $180.24 M | -3.74 | 32 | $0 |
CMRA
Comera Life Sciences Holdings, Inc. |
$0.00 | $706,969 | -0.1 | 12 | $633,102 |
CNTA
Centessa Pharmaceuticals plc |
$16.90 | $884.24 M | -6.2 | 76 | $6.85 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.67 | $1.12 B | -5.11 | 174 | $0 |
DYAI
Dyadic International, Inc. |
$1.74 | $59.06 M | -7.21 | 7 | $2.90 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.05 | $243.38 M | -1.59 | 133 | $0 |
IKNA
Ikena Oncology, Inc. |
$1.53 | $84.45 M | -1.11 | 14 | $9.16 M |
IMRX
Immuneering Corporation |
$2.25 | $40.63 M | -0.74 | 66 | $0 |
IVA
Inventiva S.A. |
$2.20 | $185.39 M | -1.34 | 123 | $17.48 M |
LRMR
Larimar Therapeutics, Inc. |
$3.78 | $611.84 M | -9.99 | 42 | $0 |
MLTX
MoonLake Immunotherapeutics |
$52.67 | $2.62 B | -57.88 | 50 | $0 |
MNPR
Monopar Therapeutics Inc. |
$22.05 | $14.18 M | -1.56 | 9 | $0 |
NAMS
NewAmsterdam Pharma Company N.V. |
$25.95 | $1.74 B | -7.15 | 62 | $12.76 M |
TERN
Terns Pharmaceuticals, Inc. |
$5.80 | $462.44 M | -5.67 | 66 | $0 |